MX2020002760A - Metodo para tratar la enfermedad alergica de las vias respiratorias (aad)/asma. - Google Patents
Metodo para tratar la enfermedad alergica de las vias respiratorias (aad)/asma.Info
- Publication number
- MX2020002760A MX2020002760A MX2020002760A MX2020002760A MX2020002760A MX 2020002760 A MX2020002760 A MX 2020002760A MX 2020002760 A MX2020002760 A MX 2020002760A MX 2020002760 A MX2020002760 A MX 2020002760A MX 2020002760 A MX2020002760 A MX 2020002760A
- Authority
- MX
- Mexico
- Prior art keywords
- aad
- asthma
- treating allergic
- airways disease
- allergic airways
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title abstract 2
- 230000000172 allergic effect Effects 0.000 title 1
- 208000010668 atopic eczema Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 abstract 2
- 208000028004 allergic respiratory disease Diseases 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
- C12N5/0692—Stem cells; Progenitor cells; Precursor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2511/00—Cells for large scale production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017903758A AU2017903758A0 (en) | 2017-09-15 | Method | |
| PCT/AU2018/050937 WO2019051536A1 (en) | 2017-09-15 | 2018-08-31 | METHOD OF TREATING ALLERGIC RESPIRATORY TRACT DISEASE (DAA) / ASTHMA |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020002760A true MX2020002760A (es) | 2020-07-20 |
Family
ID=65722228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020002760A MX2020002760A (es) | 2017-09-15 | 2018-08-31 | Metodo para tratar la enfermedad alergica de las vias respiratorias (aad)/asma. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11471493B2 (enExample) |
| EP (1) | EP3681519B1 (enExample) |
| JP (1) | JP2020533373A (enExample) |
| KR (1) | KR20200053501A (enExample) |
| CN (1) | CN111093680A (enExample) |
| AR (1) | AR112802A1 (enExample) |
| AU (1) | AU2018333272B2 (enExample) |
| BR (1) | BR112020004856A2 (enExample) |
| CA (1) | CA3074470C (enExample) |
| ES (1) | ES2996339T3 (enExample) |
| MX (1) | MX2020002760A (enExample) |
| SG (1) | SG11202001909TA (enExample) |
| TW (1) | TWI806896B (enExample) |
| WO (1) | WO2019051536A1 (enExample) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100785969B1 (ko) * | 2004-05-12 | 2007-12-14 | 동아제약주식회사 | Ｆｇｆ2를 유효성분으로 포함하는 천식 및 만성폐쇄성폐질환 예방 또는 치료제 |
| KR20210144909A (ko) * | 2010-12-17 | 2021-11-30 | 안트로제네시스 코포레이션 | 양막 유래 부착성 세포를 사용한, 면역-관련 질환 및 장애의 치료 |
| HK1206058A1 (en) * | 2012-03-07 | 2015-12-31 | Janssen Biotech, Inc. | Defined media for expansion and maintenance of pluripotent stem cells |
| WO2013151725A1 (en) * | 2012-04-05 | 2013-10-10 | The Regents Of The University Of California | Regenerative sera cells and mesenchymal stem cells |
| EP2839005B1 (en) * | 2012-04-20 | 2021-01-06 | Aptamir Therapeutics, Inc. | Mirna modulators of thermogenesis |
| US9745551B2 (en) * | 2012-07-12 | 2017-08-29 | Imstem Biotechnology, Inc. | Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof |
| WO2014024183A1 (en) * | 2012-08-06 | 2014-02-13 | Brainstorm Cell Therapeutics Ltd. | Methods of generating mesenchymal stem cells which secrete neurotrophic factors |
| AU2013360026B2 (en) * | 2012-12-12 | 2018-06-21 | Mesoblast, Inc. | Methods of treating or preventing respiratory conditions |
| CA3141731A1 (en) | 2013-03-13 | 2014-10-09 | Wisconsin Alumni Research Foundation | Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions |
| US20180221411A1 (en) * | 2014-12-19 | 2018-08-09 | Cell Ideas Pty Ltd | Improved Cell Therapies |
| CA3017772C (en) | 2016-03-16 | 2023-02-21 | Cynata Therapeutics Limited | Colony forming medium and use thereof |
| CA3071671A1 (en) * | 2016-08-04 | 2018-02-08 | Hudson Institute of Medical Research | A method of treatment |
| WO2018227244A1 (en) | 2017-06-16 | 2018-12-20 | Cynata Therapeutics Limited | Method for treating a side effect of immunotherapy |
-
2018
- 2018-08-31 CA CA3074470A patent/CA3074470C/en active Active
- 2018-08-31 KR KR1020207007796A patent/KR20200053501A/ko not_active Ceased
- 2018-08-31 EP EP18855341.6A patent/EP3681519B1/en active Active
- 2018-08-31 US US16/646,041 patent/US11471493B2/en active Active
- 2018-08-31 JP JP2020515070A patent/JP2020533373A/ja active Pending
- 2018-08-31 MX MX2020002760A patent/MX2020002760A/es unknown
- 2018-08-31 SG SG11202001909TA patent/SG11202001909TA/en unknown
- 2018-08-31 BR BR112020004856-9A patent/BR112020004856A2/pt unknown
- 2018-08-31 WO PCT/AU2018/050937 patent/WO2019051536A1/en not_active Ceased
- 2018-08-31 ES ES18855341T patent/ES2996339T3/es active Active
- 2018-08-31 CN CN201880059290.3A patent/CN111093680A/zh active Pending
- 2018-08-31 AU AU2018333272A patent/AU2018333272B2/en active Active
- 2018-09-10 TW TW107131786A patent/TWI806896B/zh active
- 2018-09-13 AR ARP180102599A patent/AR112802A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201919666A (zh) | 2019-06-01 |
| BR112020004856A2 (pt) | 2020-09-15 |
| JP2020533373A (ja) | 2020-11-19 |
| CN111093680A (zh) | 2020-05-01 |
| CA3074470A1 (en) | 2019-03-21 |
| US11471493B2 (en) | 2022-10-18 |
| WO2019051536A1 (en) | 2019-03-21 |
| EP3681519A4 (en) | 2021-04-28 |
| KR20200053501A (ko) | 2020-05-18 |
| RU2020111190A3 (enExample) | 2022-03-30 |
| CA3074470C (en) | 2024-01-16 |
| EP3681519A1 (en) | 2020-07-22 |
| TWI806896B (zh) | 2023-07-01 |
| US20200276243A1 (en) | 2020-09-03 |
| ES2996339T3 (en) | 2025-02-12 |
| AU2018333272B2 (en) | 2022-12-08 |
| RU2020111190A (ru) | 2021-10-15 |
| SG11202001909TA (en) | 2020-04-29 |
| EP3681519B1 (en) | 2024-10-30 |
| AR112802A1 (es) | 2019-12-11 |
| AU2018333272A1 (en) | 2020-03-05 |
| EP3681519C0 (en) | 2024-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269791A (en) | Treatment of asthma using anti-TSLP antibody | |
| MX2016009437A (es) | Metodo para reducir la produccion de gas total y/o la produccion de metano en un animal rumiante. | |
| EP3220986A4 (en) | Method and apparatus to measure, aid and correct the use of inhalers | |
| HK1222205A1 (zh) | 由多能干细胞产生的光感受器和光感受器袓细胞 | |
| MX2016005556A (es) | Compuestos agonistas duales de gip-glp-1 y procedimientos. | |
| PT3551748T (pt) | Células estaminais do mesênquima derivadas de tecido perinatal: método de preparação e suas utilizações | |
| EP3177207A4 (en) | Exhaled gas measurement compensation during high flow respiratory therapy | |
| IL231341B (en) | Means and method for showing the effects of correcting astigmatism with a low cylinder | |
| EP4364743A3 (en) | A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders | |
| PH12020550871A1 (en) | Process for the preparation of opicapone and intermediates thereof | |
| MX362271B (es) | Nueva forma cristalina de ciclosporina a, metodos de preparacion y metodos para su uso. | |
| ZA201701000B (en) | Attenuated bovine coronavirus and related vaccines | |
| MX2016012022A (es) | Nebulizacion de inmunoglobulina. | |
| EP3147353A4 (en) | Method for producing pancreatic blast cells and pancreatic disease treatment agent containing pancreatic blast cells | |
| TWD170487S (zh) | 喉罩氣道 | |
| MY195000A (en) | Method for the treatment of neurological disease | |
| PL3487986T3 (pl) | Sposób produkcji mikrobiologicznej określonych naturalnych kapsaicynoidów | |
| MX356317B (es) | Tratamiento de síntomas asociados a gastroparesia femenina. | |
| PH12017501872A1 (en) | Methods of treating diseases | |
| MY168066A (en) | Cigarette Production Method, Cigarette, and Double Cigarette | |
| CA2986376C (en) | Poxvirus-derived promoter, and vector comprising same | |
| MX2015017796A (es) | Preparacion de particulas secas que comprenden mentol. | |
| PH12014501280A1 (en) | Method for flattening tobacco leaves | |
| MX2020002760A (es) | Metodo para tratar la enfermedad alergica de las vias respiratorias (aad)/asma. | |
| EP3110292A4 (en) | Apparatus for ventilating fabric used to make pocketed springs and method of making strings of pocketed springs |